Suchergebnisse - "Thompson, Jeffrey C"

PubPharm (5)

1

Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression

enthalten in: Clinical lung cancer | 2024

von Friedes, C. | Yegya-Raman, N. | Zhang, S. | +13

2

Plasma Tumor Mutation Burden and Response to Pembrolizumab-Response

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Aggarwal, C. | Thompson, J. | Carpenter, E.

CommentOn: Clin Cancer Res. 2020 May 15;26(10):2354-2361. - PMID 32102950

3

Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy

enthalten in: JCO precision oncology | 2021

von Thompson, J. | Carpenter, E. | Silva, B. | +17

4

Plasma Tumor Mutation Burden and Response to Pembrolizumab-Response

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Aggarwal, C. | Thompson, J. | Carpenter, E.

CommentOn: Clin Cancer Res. 2020 May 15;26(10):2354-2361. - PMID 32102950

5

Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Aggarwal, C. | Thompson, J. | Chien, A. | +18

CommentIn: Clin Cancer Res. 2020 Jul 1;26(13):3491. - PMID 32611625

1
[1]